AnalystsYaron WerberYaron Werber's Stock Forecasts
AnalystsYaron Werber
Sectors:
Industries:
Analyst Ranking
Bottom 6%
#4321 out of 4552 analysts
Average Return
-24.51%
Win Rate
19%3 out of 16
Risk vs Reward
Poor
Good
Yaron Werber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Legend Biotech CorpLEGN | +29.52% | $51.01 | $66.07 | 2022-10-31 - 2023-10-31 | Buy |
Amgen IncAMGN | +27.54% | $246.41 | $314.26 | 2023-01-31 - 2024-01-31 | Buy |
Regeneron Pharmaceuticals IncREGN | +25.75% | $494.90 | $622.36 | 2021-02-07 - 2022-02-07 | Buy |
Amgen IncAMGN | 0.00% | $264.07 | $264.07 | 2024-04-16 - 2024-04-17 | Strong Buy |
Yaron Werber Analyst Color
Get additional color on Yaron Werber's coverage of popular stocks
Yaron Werber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amgen IncAMGN | 3 | Strong Buy | $360.00 | +36.33% | Maintains | a day ago |
Argenx SeARGX | 3 | Buy | $641.00 | +75.04% | Maintains | 4 months ago |
Biontech SeBNTX | 1 | Hold | $130.00 | N/A | Maintains | a year ago |
Fibrogen IncFGEN | 1 | Hold | $25.00 | N/A | Maintains | a year ago |
Beigene LtdBGNE | 2 | Buy | $262.00 | N/A | Maintains | a year ago |
Legend Biotech CorpLEGN | 1 | Buy | N/A | N/A | Initiates Coverage On | a year ago |
Instil Bio IncTIL | 2 | Hold | N/A | N/A | Downgrades | a year ago |
Genmab AGMAB | 1 | Hold | $38.00 | N/A | Initiates Coverage On | 2 years ago |
Bluebird Bio IncBLUE | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ascendis Pharma AASND | 1 | Hold | $136.00 | N/A | Initiates Coverage On | 2 years ago |
2seventy Bio IncTSVT | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Io Biotech IncIOBT | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Roivant Sciences LtdROIV | 1 | Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Acceleron Pharma IncXLRN | 1 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Immuneering CorpIMRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Nuvation Bio IncNUVB | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $565.00 | N/A | Maintains | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.